Literature DB >> 26830081

Pharmacokinetics of catechols in human subjects intravenously receiving XueBiJing injection, an emerging antiseptic herbal medicine.

Xiuxue Li1, Chen Cheng2, Fengqing Wang3, Yühong Huang4, Weiwei Jia3, Olajide E Olaleye3, Meijuan Li3, Yanfen Li4, Chuan Li5.   

Abstract

XueBiJing injection, prepared from a five-herb combination, is extensively used as add-on therapy in routine sepsis care in China. Catechols, derived from the component herb Salvia miltiorrhiza roots (Danshen), are probably important because of their reported antiseptic properties. This study was designed to characterize pharmacokinetics of major circulating Danshen catechols in human subjects intravenously receiving the injection at the label doses. A total of 17 Danshen catechols were detected in XueBiJing injection (content level, 0.1-139.3 μmol/L). After dosing, tanshinol and salvianolic acid B exhibited relatively high levels of systemic exposure with mean elimination half-lives of 0.38 and 0.29 h, respectively. The total plasma clearance and apparent volume of distribution at steady state of tanshinol were 1.07 L/h/kg and 0.40 L/kg, respectively, whereas those of salvianolic acid B were 0.43 L/h/kg and 0.13 L/kg, respectively. Protocatechuic acid and five other catechols were also detected in plasma but at low exposure levels. Although protocatechuic aldehyde had the highest content level in the injection, like the remaining eight catechols, it was undetected in plasma. Protocatechuic aldehyde was extensively converted into protocatechuic acid and other metabolites. The information gained here facilitates understanding the roles of Danshen catechols in therapeutic actions of XueBiJing injection.
Copyright © 2015 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Catechol; Danshen; Pharmacokinetics; Salvia miltiorrhiza roots; Sepsis; XueBiJing injection

Mesh:

Substances:

Year:  2015        PMID: 26830081     DOI: 10.1016/j.dmpk.2015.10.005

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  11 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

2.  A real-world study on adverse drug reactions to Xuebijing injection: hospital intensive monitoring based on 93 hospitals (31,913 cases).

Authors:  Rui Zheng; Hui Wang; Zhi Liu; Xiaohui Wang; Jing Li; Xiang Lei; Yilin Fan; Si Liu; Zhiqiao Feng; Hongcai Shang
Journal:  Ann Transl Med       Date:  2019-03

3.  High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care.

Authors:  Jian Li; Olajide E Olaleye; Xuan Yu; Weiwei Jia; Junling Yang; Chuang Lu; Songqiao Liu; Jingjing Yu; Xiaona Duan; Yaya Wang; Kai Dong; Rongrong He; Chen Cheng; Chuan Li
Journal:  Acta Pharm Sin B       Date:  2019-06-19       Impact factor: 11.413

4.  Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule.

Authors:  Xiao-Fang Lan; Olajide E Olaleye; Jun-Lan Lu; Wei Yang; Fei-Fei Du; Jun-Ling Yang; Chen Cheng; Yan-Hong Shi; Feng-Qing Wang; Xue-Shan Zeng; Nan-Nan Tian; Pei-Wei Liao; Xuan Yu; Fang Xu; Ying-Fei Li; Hong-Tao Wang; Nai-Xia Zhang; Wei-Wei Jia; Chuan Li
Journal:  Acta Pharmacol Sin       Date:  2021-04-30       Impact factor: 7.169

5.  Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis.

Authors:  Qi- Wu; Chuan-Hui Yin; Yi Li; Jie-Qi Cai; Han-Yun Yang; Ying-Ying Huang; Yi-Xu Zheng; Ke Xiong; Hai-Lang Yu; Ai-Ping Lu; Ke-Xin Wang; Dao-Gang Guan; Yu-Peng Chen
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

6.  Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines.

Authors:  Chuan Li; Wei-Wei Jia; Jun-Ling Yang; Chen Cheng; Olajide E Olaleye
Journal:  Acta Pharmacol Sin       Date:  2022-09-16       Impact factor: 7.169

Review 7.  Possible applications of salvianolic acid B against different cancers.

Authors:  Iram Shahzadi; Zain Ali; Sidra Bukhari; Acharan S Narula; Bushra Mirza; Reza Mohammadinejad
Journal:  Explor Target Antitumor Ther       Date:  2020-08-31

8.  Beneficial effect of Xuebijing against Pseudomonas aeruginosa infection in Caenorhabditis elegans.

Authors:  Le Zhang; Yuxing Wang; Chang Cao; Yike Zhu; Wei Huang; Yi Yang; Haibo Qiu; Songqiao Liu; Dayong Wang
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

9.  Efficacy and Safety of Xuebijing Injection Combined With Ulinastatin as Adjunctive Therapy on Sepsis: A Systematic Review and Meta-Analysis.

Authors:  Guochao Chen; Yanyan Gao; Yue Jiang; Fei Yang; Shuangshuang Li; Di Tan; Qun Ma
Journal:  Front Pharmacol       Date:  2018-07-24       Impact factor: 5.810

10.  Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans-Induced Epithelial Death in the Kidney.

Authors:  Ting Shang; Qilin Yu; Tongtong Ren; Xin-Tong Wang; Hongyan Zhu; Jia-Ming Gao; Guixiang Pan; Xiumei Gao; Yan Zhu; Yuxin Feng; Ming-Chun Li
Journal:  Front Pharmacol       Date:  2020-01-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.